Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Sloan Kettering Cancer Center


Blog Post Results (1-20 of 40)

FILTER RESULTS

Skin cancer meets its worst nightmare: IBM

The effort --- a partnership with Memorial Sloan Kettering Cancer Center --- is said to detect the disease with 97 percent accuracy.

Memorial Sloan Kettering Team Makes Key Discovery in Understanding Immunotherapy's Successes--and Its Failures

A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

'House Of Cards' Actress Elizabeth Norment Dead At 61

Elizabeth Norment, who played Frank Underwood's secretary, Nancy Kaufberger, on Netflix's "House of Cards," has died at age 61. The actress died on Oct. 13 at Memorial Sloan Kettering Cancer Center in New York City, according to The Hollywood Reporter. Show More Summary

House of Cards Actress Elizabeth Norment Dies at 61

THR reports that actress Elizabeth Norment, most recently seen playing Frank Underwood’s secretary Nancy on House of Cards, passed away on October 13th at the Sloan Kettering Cancer Center. She was 61. A staple of the Southern California theater scene, Norment also appeared in a number of film and television... More »

‘House Of Cards’ Actress Elizabeth Norment Dies At 61

House of Cards actress Elizabeth Norment has died. The actress was 61 years old and passed away on October 13 at Memorial Sloan Kettering Cancer Center. Her sister Kate confirmed the sad news to The Hollywood Reporter. As some of you...Show More Summary

Elizabeth Norment Dies; House of Cards Actress Was 61

House of Cards actress Elizabeth Norment has passed away at the age of 61. She died October 13 at Memorial Sloan Kettering Cancer Center in New York, according to her family. Further details about her death are not yet known. Norment's...Show More Summary

The Newest Precision Medicine Tool: Prostate Cancer Organoids

Research led by investigators at Memorial Sloan Kettering Cancer Center has shown for the first time that organoids derived from human prostate cancer tumors can be grown in the laboratory, giving researchers an exciting new tool to test cancer drugs and personalize cancer treatment.

Bernie Madoff’s son, Andrew, dies of lymphoma at age 48

Andrew Madoff died at Sloan Kettering Cancer Center, his lawyer told CNBC. Andrew was never charged criminally as part of his father's multi-billion dollar Ponzi scheme.

‘Second Opinion: Laetrile at Sloan-Kettering’: Movie Review

Eric Merola, director of two documentaries about the controversial cancer doctor Stanislaw Burzynski, now sets his sights on the internal cover-up of positive results for Laetrile at the Memorial Sloan Kettering Cancer Center in the 1970s.

Memorial Sloan Kettering Ranks First in the Nation for Cancer Care

Memorial Sloan Kettering Cancer Center is proud and honored to announce it has been named the number one hospital for cancer care in the nation, according to U.S. News & World Report in its annual listing of Best Hospitals.

Memorial Sloan Kettering Appoints Digitaslbi as Digital Agency of Record

Memorial Sloan Kettering Cancer Center (MSK) is partnering with DigitasLBi and Phase2 to help expand MSK's digital reach.

Teens surviving cancer get special graduation at Memorial Sloan Kettering Cancer Center

They overcame the worst that life can throw at a kid - cancer and its debilitating surgeries, fatigue, vomiting and depression.

Memorial Sloan Kettering Cancer Center and Quest Diagnostics Partner to Advance Precision Medicine in Cancer Diagnosis and Treatment

Memorial Sloan Kettering Cancer Center and Quest Diagnostics announced a joint collaboration that will utilize MSK's clinical and research insights into gene mutations associated with solid tumors. The goal is to use molecular laboratory...Show More Summary

Landmark Gift of $100 Million from the Marie-Josee and Henry R. Kravis Foundation Will Support Groundbreaking Approach to Precision Oncology

Memorial Sloan Kettering Cancer Center launched the Marie-Josee and Henry R. Kravis Center for Molecular Oncology, an ambitious initiative to improve cancer care and research through genomic analysis.

Paying It Forward: Breakthrough Prize Winners and Institutions Commit $3 Million in Support of Next Generation of Scientists

Three winners of the first-ever Breakthrough Prizes-- Charles L. Sawyers, MD, of Memorial Sloan Kettering Cancer Center; Cornelia I. Bargmann, PhD, of the Rockefeller University; and Lewis C. Cantley, PhD, of Weill Cornell Medical College...Show More Summary

DigitasLBi Takes on Memorial Sloan Kettering

We’ve been told that this has transpired in a matter of the last 24 hours, but yes, DigitasLBi has  been appointed as agency partner for Memorial Sloan Kettering, the 130-year-old private cancer center based in NYC. We’ve been told that work for the center will be handled out of the New York and Boston DigitasLBi offices. Show More Summary

Researchers discover unusual genetic mutation linked to adolescent liver cancer

In the race for better treatments and possible cures, rare diseases are often left behind. In a collaboration of researchers at The Rockefeller University, Memorial Sloan Kettering Cancer Center and the New York Genome Center (NYGC), an unusual mutation has been found that is strongly linked to one such disease: a rare liver cancer that affects teens and young adults. read more

Genetically modified T cells induced complete remissions in 88 percent of advanced leukemia patients treated

10 months agoHealth : Medical News Today

Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment. The largest clinical study ever conducted to date of patients with advanced leukemia...Show More Summary

Cell therapy shows remarkable ability to eradicate cancer in clinical study

NEW YORK, February 19, 2014 — Investigators from Memorial Sloan Kettering Cancer Center have reported more encouraging news about one of the most exciting methods of cancer treatment today. The largest clinical study ever conducted to...Show More Summary

Newly Engineered Monoclonal Antibody Shows Promise, Moves Toward Clinical Testing

Memorial Sloan Kettering Cancer Center and Eureka Therapeutics recently entered into a licensing agreement with Novartis to develop a unique monoclonal antibody.

Copyright © 2011 Regator, LLC